| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 402.89B | 408.89B | 384.82B | 344.61B | 288.21B |
| Gross Profit | 153.16B | 139.55B | 123.17B | 111.51B | 96.22B |
| EBITDA | 92.50B | 103.87B | 74.69B | 68.20B | 56.36B |
| Net Income | 15.96B | 20.30B | 29.19B | 20.13B | 18.47B |
Balance Sheet | |||||
| Total Assets | 564.42B | 548.95B | 557.41B | 501.54B | 469.98B |
| Cash, Cash Equivalents and Short-Term Investments | 62.17B | 62.95B | 54.01B | 50.47B | 45.73B |
| Total Debt | 99.05B | 93.47B | 101.19B | 100.06B | 58.68B |
| Total Liabilities | 220.44B | 210.44B | 223.99B | 205.77B | 192.12B |
| Stockholders Equity | 341.15B | 336.03B | 331.26B | 293.98B | 271.91B |
Cash Flow | |||||
| Free Cash Flow | 29.63B | 37.90B | 21.92B | -4.75B | -26.36B |
| Operating Cash Flow | 55.59B | 87.76B | 50.87B | 48.63B | 28.74B |
| Investing Cash Flow | -34.02B | -52.07B | -35.80B | -46.27B | -39.93B |
| Financing Cash Flow | -23.31B | -25.45B | -15.34B | 1.10B | -7.93B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥979.95B | 50.42 | 6.61% | 1.58% | -1.47% | -19.46% | |
75 Outperform | ¥246.31B | 9.07 | 9.02% | 3.11% | 9.57% | 40.16% | |
74 Outperform | ¥90.11B | 8.80 | 16.37% | 2.79% | 42.29% | 55.00% | |
73 Outperform | ¥789.06B | 22.03 | ― | 1.43% | 8.81% | 17.58% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥146.70B | 5.42 | 12.54% | 1.84% | 17.17% | 33.30% | |
59 Neutral | ¥232.41B | 15.21 | ― | 2.41% | 5.68% | -49.64% |